GLP-1 Weight Loss Medications: What to Know Before Starting

TL;DR GLP-1 medications like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) have transformed weight management — and they come with real considerations around side effects, long-term use, cost, and clinical supervision. Here's what the FDA and the New England Journal of Medicine evidence actually says, and what to ask your physician before you start.

In This Article

What GLP-1 Medications Actually Do

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that mimic a hormone your gut naturally releases after meals. The hormone signals your pancreas to release insulin, slows stomach emptying, and tells your brain you're full. Synthetic GLP-1 medications amplify all three effects, which is why patients eat less, feel satisfied longer, and lose weight steadily.

The two best-known are semaglutide (sold as Wegovy for weight loss and Ozempic for type 2 diabetes) and tirzepatide (Zepbound for weight loss, Mounjaro for diabetes). Tirzepatide is technically a dual agonist — it acts on both GLP-1 and a related hormone called GIP — which is why head-to-head trials have shown slightly greater weight loss with tirzepatide than semaglutide.

The Evidence Behind the Headlines

The clinical results are genuinely remarkable. The pivotal STEP-1 trial published in the New England Journal of Medicine showed that adults on semaglutide lost an average of 14.9% of their body weight over 68 weeks — versus 2.4% in the placebo group. The SURMOUNT-1 trial showed tirzepatide produced an average 20.9% weight loss at the highest dose.

Beyond weight, the SELECT trial demonstrated that semaglutide reduced major cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in adults with overweight or obesity and pre-existing heart disease — independent of weight loss. That's a category of benefit that wasn't expected when these drugs were first approved.

Common Side Effects — and How to Manage Them

The most common side effects, per the FDA prescribing information, are gastrointestinal: nausea, vomiting, diarrhea, constipation, and reflux. Most are mild, occur primarily during the dose-escalation phase, and improve over a few weeks. Eating smaller meals, avoiding high-fat foods, and staying hydrated reduces severity.

Less common but more serious risks listed on the FDA labels include pancreatitis, gallbladder disease, kidney injury (often related to dehydration from vomiting), and a theoretical risk of medullary thyroid cancer based on rodent studies — which is why these medications are contraindicated in patients with personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.

There's also active research on what's been called "Ozempic face" — the cosmetic effect of rapid weight loss on facial volume — and on muscle mass loss, which underscores the importance of resistance training and adequate protein intake while on these medications.

Who's a Good Candidate (and Who Isn't)

The FDA-approved indications are: a body mass index of 30 or higher (obesity), or a BMI of 27 or higher with at least one weight-related condition (hypertension, type 2 diabetes, sleep apnea, dyslipidemia, cardiovascular disease).

You may not be a candidate if you have a history of pancreatitis, certain thyroid cancers, severe gastroparesis, or are pregnant or planning to become pregnant. Your physician will also evaluate kidney function, gallbladder history, and any medications that interact (notably oral diabetes medications, which often need to be adjusted to prevent low blood sugar).

The drugs are also not magic. They work best as part of a structured plan that includes nutrition guidance, resistance training to preserve muscle, and behavioral support — which is exactly why pharmacy-only telehealth GLP-1 services often fall short.

What the Cost Looks Like in 2026

Out-of-pocket costs for brand-name GLP-1 medications remain high — typically $900–$1,400/month without insurance coverage. Many commercial insurance plans cover them only for type 2 diabetes, not for weight loss, though that has been gradually changing as cardiovascular benefit data accumulates.

Medicare currently covers GLP-1s for diabetes and, as of recent rulings, for cardiovascular indications in certain populations — but not for weight loss alone. Compounded versions are widely available at lower cost, but the FDA has repeatedly warned about quality and safety variability with compounded products from non-pharmacy sources.

This is one of those areas where having a real physician relationship matters: navigating coverage, manufacturer savings programs, and clinically appropriate alternatives can save patients hundreds or thousands of dollars per year.

How Long Will You Need to Take It?

This is the question patients ask most and that the science is still answering. The STEP-4 trial showed that patients who stopped semaglutide regained roughly two-thirds of the weight they'd lost within a year. That doesn't mean GLP-1s have to be lifelong — but it does mean stopping requires a transition plan, often involving dose tapering, intensive nutrition support, and ongoing behavioral changes.

For many patients, the most realistic framing is similar to medications for hypertension or cholesterol: a long-term tool used as part of an ongoing health strategy.

Why Clinical Supervision Matters More Than the Prescription

The proliferation of telehealth GLP-1 traditional medical offices has made it easy to get a prescription without much clinical evaluation — and the FDA, the Endocrine Society, and the American Medical Association have all raised concerns. A real evaluation should include baseline labs, medical history review, medication interaction screening, dose-escalation monitoring, side-effect management, and ongoing weight, muscle, and metabolic tracking.

Pharmacy-only services skip most of this. The risk isn't usually catastrophic — but the success rate is dramatically lower, and the side-effect burden is dramatically higher.

How Prime Care VIP Approaches Weight Management

We treat GLP-1 therapy like any other significant medical intervention: a real conversation, a real plan, and real follow-up. That includes baseline labs and metabolic panels, dose escalation guidance, nutrition coaching, accountability check-ins, and side-effect management — all included in your concierge membership.

If you're considering a GLP-1 medication, book a free 15-minute consultation to talk through whether it makes sense for you and what a clinically supervised plan would look like. Done right, these medications are genuinely transformative. Done poorly, they're an expensive disappointment.